Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation (MANTRA-PAF)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Danish Heart Foundation.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Jens Cosedis Nielsen, Aarhus University Hospital Identifier:
First received: August 22, 2005
Last updated: October 4, 2011
Last verified: October 2011